Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technology

Cellular and Molecular Life Sciences

Volumn 61, Issue 10, 2004, Pages 1198-1207

  Gires, O ^a   Munz M ^a   Schaffrik, M ^a   Kieu, C ^a   Rauch, J ^a   Ahlemann, M ^a   Eberle, D ^a   Mack, B ^a   Wollenberg, B ^a   Lang, S ^a   Hofmanm, T ^a   Hammerschmidt, W ^b   Zeidler, R ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Vaecgene Biotech Inc   (Germany)

Author keywords

AMIDA; CK8; HNSCC; Humoral antigens; KIAA1273 TOB3

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CYTOKERATIN 8; PROTEIN TOB3; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ARTICLE; CANCER; CANCER STAGING; CELL SURFACE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; MASS SPECTROMETRY; MEDICAL TECHNOLOGY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; VALIDATION PROCESS;

ALLERGY AND IMMUNOLOGY; ANTIBODIES; ANTIBODY FORMATION; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SEPARATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINS; MASS SPECTROMETRY; MICROSCOPY, FLUORESCENCE; PRECIPITIN TESTS; PROTEOMICS; TUMOR CELLS, CULTURED;

EID: 2542519935     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4045-8     Document Type: Article

References (34)

1. Hanash S. (2003) Disease proteomics. Nature 422: 226-232
2. Schneider C., Newman R. A., Sutherland D. R., Asser U. and Greaves M. F. (1982) A one-step purification of membrane proteins using a high efficiency immunomatrix. J. Biol. Chem. 257: 10766-10769
3. Hsu S. M, Raine L. and Fanger H. (1981) The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am. J. Clin. Pathol. 75: 816-821
4. Mintz P. J., Kim J., Do K. A., Wang X., Zinner R. G., Cristofanilli M. et al. (2003) Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat. Biotechnol. 21: 57-63
5. Skoldberg F., Ronnblom L., Thornemo M., Lindahl A., Bird P. I., Rorsman F. et al. (2002) Identification of AHNAK as a novel autoantigen in systemic lupus erythematosus. Biochem. Biophys. Res. Commun. 291: 951-958
6. KonstantinovK., Mikecz A. von, Buchwald D., Jones J., Gerace L. and Tan E. M. (1996) Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J. Clin. Invest. 98: 1888-1896
7. Ohguro H., Ogawa K., Maeda T., Maeda A. and Maruyama I. (1999) Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Invest. Ophthalmol. Vis. Sci. 40: 3160-3167
8. Hembrough T. A., Li L. and Gonias S. L. (1996) Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J. Biol. Chem. 271: 25684-25691
9. HembroughT. A., Vasudevan J., Allietta M. M., Glass W. F. and Gonias S. L. (1995) A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J. Cell Sci. 108: 1071-1082
10. Wells M. J., Hatton M. W., Hewlett B., Podor T. J., Sheffield W. P. and Blajchman M. A. (1997) Cytokeratin 18 is expressed on the hepatocyte plasma membrane surface and interacts with thrombin-antithrombin complexes. J. Biol. Chem. 272: 28574-28581
11. Baizar M., Winter M. J., Boer C. J. de and Litvinov S. V. (1999) The biology of the 17-1A antigen (Ep-CAM). J. Mol. Med. 77: 699-712
12. De Jager W., Te Velthuis H., Prakken B. J., Kuis W. and Rijkers G. T. (2003) Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 10: 133-139
13. Gharib T. G., Chen G., Wang H., Huang C. C., Prescott M. S., Shedden K. et al. (2002) Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia 4: 440-448
14. Fukunaga Y., Bandoh S., Fujita J., Yang Y., Ueda Y., Hojo S. et al. (2002) Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients. Lung Cancer 38: 31-38
15. Punglia R. S., D'Amico A. V., Catalona W. J., Roehl K. A. and Kuntz K. M. (2003) Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N. Engl. J. Med. 349: 335-342
16. Zeller K. I., Jegga A. G., Aronow B. J., O'Donnell K. A. and Dang C. V. (2003) An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol. 4: R69
17. Dang C. V., Resar L. M., Emison E., Kim S., Li Q., Prescott J. E. et al. (1999) Function of the c-Myc oncogenic transcription factor. Exp. Cell Res. 253: 63-77
18. Boxer L. M. and Dang C. V. (2001) Translocations involving c-myc and c-myc function. Oncogene 20: 5595-5610
19. Rodrigo J. P., Lazo P. S., Ramos S., Alvarez I. and Suarez C. (1996) MYC amplification in squamous cell carcinomas of the head and neck. Arch. Otolaryngol. Head Neck Surg. 122: 504-507
20. Pauli C., Munz M., Kieu C., Mack B., Breinl P., Wollenberg B. et al. (2003) Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas. Cancer Lett. 193: 25-32
21. Vaidya M. M., Sawant S. S., Borges A. M., Naresh N. K., Purandare M. C. and Bhisey A. N. (2000) Cytokeratin expression in human fetal tongue and buccal mucosa. J. Biosci. 25: 235-242
22. Nagase T., Kikuno R. and Ohara O. (2001) Prediction of the coding sequences of unidentified human genes. XXII. The complete sequences of 50 new cDNA clones which code for large proteins. DNA Res. 8: 319-327
23. Ross C. D., Gomaa M. A., Gillies E., Juengel R. and Medina J. E. (2000) Tumor grade, microvessel density, and activities of malate dehydrogenase, lactate dehydrogenase, and hexokinase in squamous cell carcinoma. Otolaryngol. Head Neck Surg. 122: 195-200
24. Aso T., Yamazaki K., Amimoto K., Kuroiwa A., Higashi H., Matsuda Y. et al. (2000) Identification and characterization of Elongin A2, a new member of the Elongin family of transcription elongation factors, specifically expressed in the testis. J. Biol. Chem. 275: 6546-6552
25. Perry S. V. (2001) Vertebrate tropomyosin: distribution, properties and function. J. Muscle Res. Cell Motil. 22: 5-49
26. Leyva J. A. (2003) Understanding ATP synthesis: structure and mechanism of the F1-ATPase. Mol. Membr. Biol. 20: 27-33
27. Xue C., Takahashi M., Hasunuma T., Aono H., Yamamoto K., Yoshino S. et al. (1997) Characterisation of fibroblast-like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondrocytes. Ann. Rheum. Dis. 56: 262-267
28. Bachvaroff R. J., Miller F. and Rapaport F. T. (1980) Appearance of cytoskeletal components on the surface of leukemia cells and of lymphocytes transformed by mitogens and Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 77: 4979-4983
29. Aubry M., Marineau C., Zhang F. R., Zahed L., Figlewicz D., Delattre O. et al. (1992) Cloning of six new genes with zinc finger motifs mapping to short and long arms of human acrocentric chromosome 22 (p and q11.2). Genomics 13: 641-648
30. Meza-Zepeda L. A., Forus A., Lygren B., Dahlberg A. B., Godager L. H., South A. P. et al. (2002) Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene. 21: 2261-2269
31. Kobayashi S., Tanaka T., Matsuyoshi N. and Imamura S. (1996) Keratin 9 point mutation in the pedigree of epidermolytic hereditary palmoplantar keratoderma perturbs keratin intermediate filament network formation. FEBS Lett. 386: 149-155
32. Wang K., Knipfer M., Huang Q. Q., Heerden A. van, Hsu L. C., Gutierrez G. et al. (1996) Human skeletal muscle nebulin sequence encodes a blueprint for thin filament architecture: sequence motifs and affinity profiles of tandem repeats and terminal SH3. J. Biol. Chem. 271: 4304-4314
33. Long G. L., ChandraT., Woo S. L., Davie E. W. and Kurachi K. (1984) Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry. 23: 4828-4837
34. Arlaud G. J., Gaboriaud C., Garnier G., Circolo A., Thielens N. M., Budayova-Spano M. et al. (2002) Structure, function and molecular genetics of human and murine C1r. Immunobiology 205: 365-382